Portfolio company
ViroCell
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company designs and manufactures viral vectors for academic and corporate innovators developing cell and gene therapies for clinical trials.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genezen
This company manufactures viral vectors for biotechnology and pharmaceutical firms developing cell and gene therapies.
SIRION Biotech
The company develops and manufactures viral vector technologies for researchers and pharmaceutical firms in the cell and gene therapy sectors.
Fuse Vectors
This company develops a cell-free enzymatic platform to manufacture viral vectors for pharmaceutical and biotechnology clients to produce gene therapies.
VIVEbiotech
VIVEbiotech manufactures lentiviral vectors for pharmaceutical and biotechnology companies developing gene and cell therapies.
Vibalogics
The company provides contract development and manufacturing services for virotherapy products to biopharmaceutical firms developing vaccines, gene therapies and oncolytic viral treatments.
Carroucell
This company manufactures flat microcarriers for cell culture in bioreactors for biopharmaceutical customers developing cell and gene therapies.
PharmaCell
The company provides contract manufacturing and development services for cell and gene therapy products to pharmaceutical and biotechnology clients.
Brammer Bio
This contract development and manufacturing organisation produces viral vectors for pharmaceutical and biotechnology companies developing gene and cell therapies.